Premium Parent, LLC acquires Premier, Inc. (2025)

Deal facts

Buyer: Premium Parent, LLC
Target: Premier, Inc.
Deal value: Not disclosed
Announced: 21 September 2025
Status: Completed
Sector: Healthcare
Country: United States
Consideration: cash

Sources

SEC_EDGAR_8K

What we know

More M&A Tools

Explore the Toolkit

Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.

Access now

Deal timeline

1 update

25 Nov 2025CompletedClosed
Premium Parent, LLC completes acquisition of Premier, Inc.
Introductory Note On September 21, 2025, Premier, Inc. (“ Premier ” or the “ Company ”) entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) by and among the Company, Premium Parent, LLC, a Delaware limited liability company (“ Parent ”), and Premium Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“ Merger Sub ”). The Merger Agreement provides tha
Source

OpinionExit Mode editorial

We see a clear signal in the completed acquisition of Premier, Inc by Premium Parent, LLC. This transaction moves a major US healthcare entity from public markets into private ownership. The deal structure is straightforward: a cash offer that removes the target from public listing. There is no public valuation attached to this announcement, yet the mechanism itself speaks volumes. When a buyer elects to take a company private using cash, they are betting on long-term operational freedom rather than quarterly earnings pressure. This is a decisive shift in strategy for the sector.

The choice of a going-private route often reflects a desire to restructure without the noise of public scrutiny. For the SME founder reading this, the lesson is about timing and structure. Public markets demand transparency that can sometimes stifle necessary, painful changes. A private buyer can absorb short-term disruption to build long-term value. The cash consideration confirms that the buyer has secured the liquidity to execute immediately. This removes the uncertainty of stock-based deals and eliminates the need for shareholder approval battles that often derail complex transactions. It is a clean break from public reporting cycles.

Regulatory clearance in the US healthcare sector is never trivial. Even with a cash deal, competition authorities will scrutinise the combined entity to ensure it does not stifle market competition. The buyer must navigate anti-trust thresholds and potential change-of-control covenants embedded in existing debt or contracts. These are not mere formalities; they are concrete hurdles that can delay or alter the final terms. The speed of completion suggests that the parties have already addressed these regulatory and commercial contingencies. This efficiency is a hallmark of well-prepared private equity or strategic buyers who understand the stakes.

Do not wait for a public market rally to consider your exit options if your business model requires significant restructuring. This week, review your current debt covenants and identify any change-of-control clauses that could trigger early repayment or restrict a sale. Understanding these constraints now will determine whether you can execute a clean, cash-based exit when the right private buyer appears.

Editorial opinion. Not financial or legal advice.

Explore

Browse adjacent archives

Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.

More Healthcare deals More 2025 deals More going private deals More from Premium Parent, LLC All M&A deals

Similar deals

Other Healthcare M&A activity tracked by Exit Mode.

28 July 2026CompletedHealthcare

CCP PAW 2 LIMITED to acquire ANIMALCARE GROUP PLC

CCP PAW 2 Limited has agreed to acquire Animalcare Group Plc in a going private transaction. The deal was announced and completed on 30 July 2026. Both the buyer and the…

Buyer: CCP PAW 2 LIMITED
Target: ANIMALCARE GROUP PLC
Deal value: Not disclosed
Deal type: going private

Read deal Healthcare deals going private deals United Kingdom deals

6 July 2026CompletedHealthcare

Trafalgar Asset Management, LLC to acquire The Greater Cannabis Company, Inc.

Trafalgar Asset Management, LLC has agreed to acquire The Greater Cannabis Company, Inc. in a going private transaction. The deal was announced on 6 July 2026, following…

Buyer: Trafalgar Asset Management, LLC
Target: The Greater Cannabis Company, Inc.
Deal value: Not disclosed
Deal type: going private

Read deal Healthcare deals going private deals United States deals

30 June 2026CompletedHealthcare

Hanmi Pharmaceuticals Co. Ltd. to acquire Aptose Biosciences Inc.

Hanmi Pharmaceuticals Co. Ltd. has agreed to acquire Aptose Biosciences Inc. in a going private transaction valued at USD 3,466,470. The consideration for this deal cons…

Buyer: Hanmi Pharmaceuticals Co. Ltd.
Target: Aptose Biosciences Inc.
Deal value: USD 3,466,470
Deal type: going private

Read deal Healthcare deals going private deals Canada deals

9 June 2026CompletedHealthcare

GlaxoSmithKline LLC to acquire Nuvalent, Inc.

GlaxoSmithKline LLC has agreed to acquire Nuvalent, Inc. in a going private transaction. The deal was announced on 9 June 2026 and completed on 15 July 2026. The conside…

Buyer: GlaxoSmithKline LLC
Target: Nuvalent, Inc.
Deal value: Not disclosed
Deal type: going private

Read deal Healthcare deals going private deals United States deals

3 June 2026CompletedHealthcare

FONAR, LLC to acquire FONAR Corporation

FONAR, LLC has agreed to acquire FONAR Corporation in a going private transaction completed on 3 June 2026. The deal involves the purchase of the US-based healthcare com…

Buyer: FONAR, LLC
Target: FONAR Corporation
Deal value: Not disclosed
Deal type: going private

Read deal Healthcare deals going private deals United States deals

Buyer history